| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,371,985 | 1,422,670 | 1,394,636 | 1,680,518 | | Cost of Revenue | 1,166,740 | 1,207,786 | 1,201,477 | 1,433,349 | | | Gross Profit | 205,245 | 214,884 | 193,159 | 247,169 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 137,895 | 136,974 | 127,795 | 144,543 | | Non Recurring | 90 | 3,050 | 1,060 | 1,686 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 67,260 | 74,860 | 64,304 | 100,940 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 788 | 1,086 | 1,542 | 2,345 | | Earnings Before Interest And Taxes | 68,048 | 75,946 | 65,846 | 102,612 | | Interest Expense | 1,947 | 1,900 | 1,793 | 2,604 | | Income Before Tax | 66,101 | 74,046 | 64,053 | 100,008 | | Income Tax Expense | 25,624 | 28,818 | 26,682 | 39,721 | | Minority Interest | (1,503) |
-
|
-
| (673) | | | | Net Income From Continuing Ops | 38,974 | 45,228 | 37,371 | 60,287 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 38,974 | 45,228 | 37,371 | 60,287 | | Preferred Stock And Other Adjustments | 1,012 | (409) | (603) |
-
| | | Net Income Applicable To Common Shares | $39,986 | $44,819 | $36,768 | $60,287 |
|
0.31% Nasdaq 
0.05%
Income Statement
